A 42-year-old woman with chronic rhinosinusitis and recurrent nasal polyps has failed 3 months of intranasal mometasone therapy. Polyps remain large and symptomatic, causing significant nasal obstruction. Endoscopic sinus surgery is planned. Which agent is most appropriate as adjunctive pharmacotherapy to reduce polyp recurrence post-operatively?